Join
Live feed
·
INSIDERFilingvia Quantisnow
Cytokinetics Incorporated logo

EVP, Chief Commercial Officer Callos Andrew sold $104,300 worth of shares (1,709 units at $61.03), decreasing direct ownership by 4% to 46,149 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CYTK· Cytokinetics Incorporated
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CYTK (Cytokinetics Incorporated) and more on Quantisnow.